Johnson-Levonas AO - Search Results

1

Single therapeutic and supratherapeutic doses of anacetrapib, a cholesteryl ester transfer protein inhibitor, do not prolong the QTcF interval in healthy volunteers.

Lauring B, Liu Y, Li XS, Larson P, Moreau A, Farmer HF, Johnson-Levonas AO, Wagner JA, Lai E. Lauring B, et al. J Clin Pharmacol. 2014 Jul;54(7):765-75. doi: 10.1002/jcph.278. Epub 2014 Mar 6. J Clin Pharmacol. 2014. PMID: 24615657 Clinical Trial.

2

Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin.

Krauss RM, Pinto CA, Liu Y, Johnson-Levonas AO, Dansky HM. Krauss RM, et al. J Clin Lipidol. 2015 Jan-Feb;9(1):93-102. doi: 10.1016/j.jacl.2014.09.013. Epub 2014 Oct 13. J Clin Lipidol. 2015. PMID: 25670366 Free PMC article. Clinical Trial.

3

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects.

Thomas T, Zhou H, Karmally W, Ramakrishnan R, Holleran S, Liu Y, Jumes P, Wagner JA, Hubbard B, Previs SF, Roddy T, Johnson-Levonas AO, Gutstein DE, Marcovina SM, Rader DJ, Ginsberg HN, Millar JS, Reyes-Soffer G. Thomas T, et al. Among authors: johnson levonas ao. Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1770-1775. doi: 10.1161/ATVBAHA.117.309549. Epub 2017 Jul 20. Arterioscler Thromb Vasc Biol. 2017. PMID: 28729361 Free PMC article. Clinical Trial.

4

Multiple doses of sitagliptin, a selective DPP-4 inhibitor, do not meaningfully alter pharmacokinetics and pharmacodynamics of warfarin.

Wright DH, Herman GA, Maes A, Liu Q, Johnson-Levonas AO, Wagner JA. Wright DH, et al. J Clin Pharmacol. 2009 Oct;49(10):1157-67. doi: 10.1177/0091270009341653. J Clin Pharmacol. 2009. PMID: 19783710 Clinical Trial.

5

A single supratherapeutic dose of rolofylline does not prolong the QTcF interval in healthy volunteers.

Radziszewski W, Lai E, Lazarus Shipitofsky N, Stroh M, Dishy V, Han L, Lewis W, Johnson-Levonas AO, Lutz R, Wagner J. Radziszewski W, et al. Am J Ther. 2010 Jan-Feb;17(1):8-16. doi: 10.1097/MJT.0b013e3181c3cbdb. Am J Ther. 2010. PMID: 20027105 Clinical Trial.

6

Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.

Luo WL, Crumley T, Ebel D, Atiee GJ, Royalty J, Johnson-Levonas AO, Wagner J, Lai E. Luo WL, et al. J Clin Pharmacol. 2010 Nov;50(11):1273-9. doi: 10.1177/0091270009360042. Epub 2010 Jan 27. J Clin Pharmacol. 2010. PMID: 20107202 Clinical Trial.

7

Effects of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the steady-state pharmacokinetics of digoxin in healthy adult subjects.

Liu F, Vessey L, Wenning L, Connolly S, Buckland M, Johnson-Levonas AO, Denker A, Wagner JA, Lai E. Liu F, et al. J Clin Pharmacol. 2010 Jul;50(7):823-8. doi: 10.1177/0091270009356571. Epub 2010 Mar 2. J Clin Pharmacol. 2010. PMID: 20197486 Clinical Trial.

8

Pharmacokinetics of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, in patients with moderate hepatic impairment.

Wang YH, Liu F, Luk JA, Nirula A, Johnson-Levonas AO, Lasseter KC, Marbury TC, Lunde NM, Wagner JA, Lai E. Wang YH, et al. J Clin Pharmacol. 2011 Mar;51(3):406-12. doi: 10.1177/0091270010369240. Epub 2010 May 19. J Clin Pharmacol. 2011. PMID: 20484612 Clinical Trial.

9

Sitagliptin, a dipeptidyl peptidase-4 inhibitor, does not affect the pharmacokinetics of ethinyl estradiol or norethindrone in healthy female subjects.

Migoya E, Larson P, Bergman A, Miller J, Johnson-Levonas AO, Lasseter KC, Wagner JA. Migoya E, et al. J Clin Pharmacol. 2011 Sep;51(9):1319-25. doi: 10.1177/0091270010381497. Epub 2011 Jan 5. J Clin Pharmacol. 2011. PMID: 21209231 Clinical Trial.

10

Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects.

Krishna R, Addy C, Tatosian D, Glasgow XS, Gendrano Iii IN, Robberechts M, Haazen W, de Hoon JN, Depré M, Martucci A, Peng JZ, Johnson-Levonas AO, Wagner JA, Stoch SA. Krishna R, et al. J Clin Pharmacol. 2016 Dec;56(12):1528-1537. doi: 10.1002/jcph.773. Epub 2016 Jun 17. J Clin Pharmacol. 2016. PMID: 27225334 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters